IL10 and myeloid sarcoma: Since many documented positive correlations between IL-10 and MS remission have been documented, and IL-10 secreting Tr1 usage in pre-clinical models appears useful, upregulation of Tr1 cells could be a useful IL-10 replenishment strategy which would also rectify Tr1 defects in MS [146, 147].